UPDATE: Morgan Stanley Reiterates on athenahealth on Mixed Factors

Loading...
Loading...
In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on
athenahealthATHN
, but removed the $133.00 price target. In the report, Morgan Stanley noted, “First clients for Coordinator Enterprise offering announced, Steward Healthcare, a mid-sized health system (11 hospitals, ~2,100 beds, net oper. revs. of $1.9B and Griffin Hospital (160 bed hospital, with net oper. revs of $130M). Initially, early adopter revenue model is subject to at-risk outcomes, tied to ROI and measured savings metrics. If proof-of-concept materializes, at ATHN's stated goal pricing of 1% of revenues, we estimate these contracts would amount to ~$20M in annual revenues. According to management, measurable outcome data will be available within first 12 month of contract.” athenahealth closed on Thursday at $145.58.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorPrice TargetAnalyst RatingsMorgan StanleyRicky R. Goldwasser
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...